EU Says Pradaxa Treatment Requires Kidney Test - MedPage Today |
![]() |
MedPage Today The manufacturer of dabigatran etexilate (Pradaxa) will tell European prescribers that renal function testing is a must when starting patients on the drug. Boehringer Ingelheim agreed that renal function ... Renal-assessment update issued for dabigatran TheHeart.Org Boehringer Ingelheim Implements Additional Guidance Supporting Appropriate Use |